These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3061075)

  • 1. Sensitivity of graft rejection in rats to local immunosuppressive therapy.
    Ruers TJ; Daemen MJ; Thijssen HH; van der Linden CJ; Buurman WA
    Transplantation; 1988 Dec; 46(6):820-5. PubMed ID: 3061075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft rejection can be treated effectively by local immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1127-9. PubMed ID: 2650075
    [No Abstract]   [Full Text] [Related]  

  • 3. Budesonide, a locally acting steroid, prevents graft rejection in a rat model of intestinal transplantation.
    Ozcay N; Fryer J; Grant D; Freeman D; Garcia B; Zhong R
    Transplantation; 1997 May; 63(9):1220-5. PubMed ID: 9158013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat.
    Lee CJ; Yoshimura N; Shiho O; Kita M; Oka T
    Clin Exp Immunol; 1993 Mar; 91(3):362-7. PubMed ID: 7680292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local immunosuppression with budesonide after liver transplantation in the rat: a preliminary histomorphological analysis.
    Weber T; Kalbhenn T; Herrmann G; Hanisch E
    Transplantation; 1997 Sep; 64(5):705-8. PubMed ID: 9311706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats.
    Yano K; Fukuda Y; Sumimoto R; Ito H; Sumimoto K; Dohi K
    Transpl Int; 1994; 7 Suppl 1():S187-93. PubMed ID: 11271200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients.
    Wang X; Alfrey EJ; Posselt A; Tafra L; Alak AM; Dafoe DC
    Transpl Int; 1995; 8(4):268-72. PubMed ID: 7546148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of liver allograft rejection by administration of 15-deoxyspergualin. Comparison of administration via the hepatic artery, portal vein, or systemic circulation.
    Yano K; Fukuda Y; Sumimoto R; Sumimoto K; Ito H; Dohi K
    Transpl Int; 1994 May; 7(3):149-56. PubMed ID: 8060462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local budesonide treatment of rat cardiac allografts results in effective immunosuppression without systemic immunological side effects.
    Ruers TJ; Buurman WA; Daemen MJ; van der Linden CJ; Kootstra G
    Transplant Proc; 1990 Aug; 22(4):1998-9. PubMed ID: 2389507
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular proliferation at the site of organ allografts and the influence of immunosuppressive therapy.
    Ruers TJ; Schutte B; van der Linden CJ; Buurman WA
    Transplantation; 1990 Oct; 50(4):568-72. PubMed ID: 2219275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local treatment of renal allografts, a promising way to reduce the dosage of immunosuppressive drugs. Comparison of various ways of administering prednisolone.
    Ruers TJ; Buurman WA; Smits JF; van der Linden CJ; van Dongen JJ; Struyker-Boudier HA; Kootstra G
    Transplantation; 1986 Feb; 41(2):156-61. PubMed ID: 3511577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study.
    Hautz T; Krapf C; Grahammer J; Zelger B; Hickethier T; Seger C; Eberhart N; Wallner C; Messner F; Kotsch K; Griesmacher A; Brandacher G; Lee WP; Margreiter R; Pratschke J; Glossmann H; Schneeberger S
    Transpl Int; 2013 May; 26(5):552-61. PubMed ID: 23489391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological observations in rat kidney allografts after local steroid administration.
    Ruers TJ; Buurman WA; van Boxtel CJ; van der Linden CJ; Kootstra G
    J Exp Med; 1987 Nov; 166(5):1205-20. PubMed ID: 3119756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.